Matches in SemOpenAlex for { <https://semopenalex.org/work/W3094211435> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W3094211435 abstract "Aranoza (3-a-L-arabinopyranosyl-1-methyl-nitrosourea) is nitrosourea derivative, as streptozotocin STZ. O6-methylguanine DNA methyltransferase (MGMT) is an enzyme involved in chemotherapy resistance to alkalyting agents. Material and methods. There were observed 117patients with neuroendocrine neoplasms (NENs) received Aranoza-based therapy. They included 52 cases with pancreatic neuroendocrine tumors (P-NETs), 52 patients with non-pancreatic (notP-NETs, 13 NET patients with metastases without revealed primary tumor focus). There was investigated the radiologic response to the treatment according to Response Evaluation Criteria In Solid Tumors (RECIST) Score, version 1.0), biochemical response, median progression-free survival (PFS) by Kaplan-Meier estimator), toxicity (according to Common Terminology Criteria for Adverse Events (CTCAE), version 3.0) and the impact of MGMT expression (immunohistochemistry method) in tumor tissue on the efficacy of the treatment. Results. Objective response rate (ORR) in PNET cases accounted for 39% (20/52) whereas in nonP-NETpatients - 12% (6/52) (p = 0.0032). Median PFS accounted for 15.3 months in PNET patients and 16.6 months in non-PNET cases (p = 0.78). The most common types of the toxicity grade III-IV included thrombocytopenia (17from 871 courses) and neutropenia (11 from 871 courses). In samples of the tumor tissue the lack of MGMT expression was observed in 29 out of 35 P-NET cases, 12 out of 31 non-PNET cases (p = 0,0006). Objective response was recorded in 20 of 44 patients with MGMT-deficient tumors and in 1 out of 27patients with MGMT intact tumors (p = 0.0001). In the lack and presence of the MGMT expression in the tumor tissue median PFS accounted for 20.6 months and 14.4 months correspondingly (p = 0,022). Conclusion. Aranoza-based therapy demonstrated an antitumor activity and good safety profile in NENpatientss. MGMT deficiency in PNETs was more common than in non-PNETs and explained the susceptibility of some PNETs to treatment." @default.
- W3094211435 created "2020-10-29" @default.
- W3094211435 creator A5007741115 @default.
- W3094211435 creator A5019132743 @default.
- W3094211435 creator A5020925911 @default.
- W3094211435 creator A5024256957 @default.
- W3094211435 creator A5030952776 @default.
- W3094211435 creator A5041661465 @default.
- W3094211435 creator A5047847690 @default.
- W3094211435 creator A5052243709 @default.
- W3094211435 creator A5052978985 @default.
- W3094211435 creator A5065881957 @default.
- W3094211435 creator A5075628915 @default.
- W3094211435 date "2016-12-15" @default.
- W3094211435 modified "2023-09-27" @default.
- W3094211435 title "Efficacy and safety of aranoza-based therapy in neuroendocrine neoplasms. Prognostic role of O6-methylguanine DNA methyltransferase expression in tumor tissue" @default.
- W3094211435 cites W1979469384 @default.
- W3094211435 cites W2011916383 @default.
- W3094211435 cites W2118672029 @default.
- W3094211435 cites W2130735070 @default.
- W3094211435 doi "https://doi.org/10.18821/10289984-2016-21-6-293-299" @default.
- W3094211435 hasPublicationYear "2016" @default.
- W3094211435 type Work @default.
- W3094211435 sameAs 3094211435 @default.
- W3094211435 citedByCount "0" @default.
- W3094211435 crossrefType "journal-article" @default.
- W3094211435 hasAuthorship W3094211435A5007741115 @default.
- W3094211435 hasAuthorship W3094211435A5019132743 @default.
- W3094211435 hasAuthorship W3094211435A5020925911 @default.
- W3094211435 hasAuthorship W3094211435A5024256957 @default.
- W3094211435 hasAuthorship W3094211435A5030952776 @default.
- W3094211435 hasAuthorship W3094211435A5041661465 @default.
- W3094211435 hasAuthorship W3094211435A5047847690 @default.
- W3094211435 hasAuthorship W3094211435A5052243709 @default.
- W3094211435 hasAuthorship W3094211435A5052978985 @default.
- W3094211435 hasAuthorship W3094211435A5065881957 @default.
- W3094211435 hasAuthorship W3094211435A5075628915 @default.
- W3094211435 hasConcept C126322002 @default.
- W3094211435 hasConcept C143998085 @default.
- W3094211435 hasConcept C2779066768 @default.
- W3094211435 hasConcept C2779527866 @default.
- W3094211435 hasConcept C33288867 @default.
- W3094211435 hasConcept C502942594 @default.
- W3094211435 hasConcept C54355233 @default.
- W3094211435 hasConcept C552990157 @default.
- W3094211435 hasConcept C71924100 @default.
- W3094211435 hasConcept C86803240 @default.
- W3094211435 hasConcept C91965660 @default.
- W3094211435 hasConceptScore W3094211435C126322002 @default.
- W3094211435 hasConceptScore W3094211435C143998085 @default.
- W3094211435 hasConceptScore W3094211435C2779066768 @default.
- W3094211435 hasConceptScore W3094211435C2779527866 @default.
- W3094211435 hasConceptScore W3094211435C33288867 @default.
- W3094211435 hasConceptScore W3094211435C502942594 @default.
- W3094211435 hasConceptScore W3094211435C54355233 @default.
- W3094211435 hasConceptScore W3094211435C552990157 @default.
- W3094211435 hasConceptScore W3094211435C71924100 @default.
- W3094211435 hasConceptScore W3094211435C86803240 @default.
- W3094211435 hasConceptScore W3094211435C91965660 @default.
- W3094211435 hasLocation W30942114351 @default.
- W3094211435 hasOpenAccess W3094211435 @default.
- W3094211435 hasPrimaryLocation W30942114351 @default.
- W3094211435 hasRelatedWork W1554631561 @default.
- W3094211435 hasRelatedWork W1963591138 @default.
- W3094211435 hasRelatedWork W2002500034 @default.
- W3094211435 hasRelatedWork W2059049599 @default.
- W3094211435 hasRelatedWork W2078667607 @default.
- W3094211435 hasRelatedWork W2128292637 @default.
- W3094211435 hasRelatedWork W2163598152 @default.
- W3094211435 hasRelatedWork W2242821333 @default.
- W3094211435 hasRelatedWork W2279302958 @default.
- W3094211435 hasRelatedWork W2506281344 @default.
- W3094211435 hasRelatedWork W2588406559 @default.
- W3094211435 hasRelatedWork W2591076327 @default.
- W3094211435 hasRelatedWork W2607455105 @default.
- W3094211435 hasRelatedWork W2620622663 @default.
- W3094211435 hasRelatedWork W2626795850 @default.
- W3094211435 hasRelatedWork W3047241006 @default.
- W3094211435 hasRelatedWork W3108007888 @default.
- W3094211435 hasRelatedWork W3191065869 @default.
- W3094211435 hasRelatedWork W3208385442 @default.
- W3094211435 hasRelatedWork W2624699444 @default.
- W3094211435 isParatext "false" @default.
- W3094211435 isRetracted "false" @default.
- W3094211435 magId "3094211435" @default.
- W3094211435 workType "article" @default.